Scarica l'app Stockscreener
17.56
3.94%
-0.72
Dopo l'orario di chiusura:
17.50
-0.06
-0.34%
Precedente Chiudi:
$18.28
Aprire:
$18.08
Volume 24 ore:
1.09M
Relative Volume:
1.06
Capitalizzazione di mercato:
$1.21B
Reddito:
$161.10M
Utile/perdita netta:
$-308.60M
Rapporto P/E:
-3.7602
EPS:
-4.67
Flusso di cassa netto:
$-259.90M
1 W Prestazione:
+8.19%
1M Prestazione:
-7.43%
6M Prestazione:
-31.16%
1 anno Prestazione:
-62.67%
Intervallo 1D:
$17.22
$18.45
Intervallo di 1 settimana:
$16.41
$18.93
Portata 52W:
$16.07
$47.24
Arvinas Inc Stock (ARVN) Company Profile
Nome
Arvinas Inc
Settore
Industria
Telefono
203-535-1456
Indirizzo
395 WINCHESTER AVE, NEW HAVEN, CT
Confronta ARVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARVN
Arvinas Inc
|
17.56 | 1.21B | 161.10M | -308.60M | -259.90M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.01 | 128.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.83 | 81.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
571.00 | 34.69B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.07 | 30.17B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
242.66 | 26.02B | 3.32B | -860.46M | -1.04B | -8.32 |
Arvinas Inc Stock (ARVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-11-18 | Iniziato | Stephens | Overweight |
| 2024-02-28 | Reiterato | Oppenheimer | Outperform |
| 2024-02-14 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-01 | Iniziato | Goldman | Buy |
| 2023-12-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-11-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-10-23 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-01-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-01-03 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-09-09 | Iniziato | Barclays | Overweight |
| 2022-06-21 | Iniziato | Jefferies | Hold |
| 2022-05-09 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-04-28 | Iniziato | Credit Suisse | Outperform |
| 2022-04-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-02-11 | Ripresa | BMO Capital Markets | Outperform |
| 2022-02-10 | Iniziato | Wells Fargo | Overweight |
| 2022-01-19 | Iniziato | Goldman | Buy |
| 2021-12-07 | Iniziato | Cowen | Outperform |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-09-30 | Iniziato | Stifel | Buy |
| 2021-09-09 | Iniziato | BofA Securities | Buy |
| 2021-05-21 | Iniziato | UBS | Buy |
| 2021-04-21 | Iniziato | Truist | Buy |
| 2021-03-31 | Iniziato | BMO Capital Markets | Outperform |
| 2020-12-14 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-06-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-05-12 | Iniziato | Oppenheimer | Perform |
| 2019-12-19 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-25 | Iniziato | Guggenheim | Buy |
| 2019-10-24 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-09-25 | Iniziato | Wedbush | Outperform |
| 2019-09-12 | Iniziato | BMO Capital Markets | Outperform |
| 2019-08-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-05 | Downgrade | Citigroup | Buy → Neutral |
| 2019-04-12 | Iniziato | Evercore ISI | Outperform |
| 2018-10-22 | Iniziato | Citigroup | Buy |
| 2018-10-22 | Iniziato | Goldman | Neutral |
| 2018-10-22 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Arvinas Inc Borsa (ARVN) Ultime notizie
Arvinas (NASDAQ:ARVN) Shares Up 4.8%Here's Why - MarketBeat
Lisa Sinclair, 2025 Women in Business Honoree - Hartford Business Journal
Citigroup Lowers Arvinas (NASDAQ:ARVN) Price Target to $19.00 - Defense World
Traders Purchase High Volume of Call Options on Arvinas (NASDAQ:ARVN) - MarketBeat
Arvinas (NASDAQ:ARVN) Price Target Lowered to $19.00 at Citigroup - MarketBeat
Candriam S.C.A. Sells 20,845 Shares of Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
(ARVN) Investment Analysis and Advice - Stock Traders Daily
Arvinas (NASDAQ:ARVN) Reaches New 52-Week LowHere's What Happened - MarketBeat
Arvinas Target of Unusually High Options Trading (NASDAQ:ARVN) - Defense World
Arvinas, Inc. (NASDAQ:ARVN) Shares Sold by New York State Common Retirement Fund - Defense World
Rhumbline Advisers Acquires 754 Shares of Arvinas, Inc. (NASDAQ:ARVN) - Defense World
Arvinas to Participate in Upcoming Investor Conferences - GlobeNewswire
Biotech Spotlight: How to Access Arvinas' Upcoming Investor Presentations at 3 Key Conferences - StockTitan
Arvinas stock touches 52-week low at $15.98 amid market challenges - Investing.com
Wall Street Analysts Predict a 228.87% Upside in Arvinas (ARVN): Here's What You Should Know - MSN
Arvinas, Inc. (NASDAQ:ARVN) Insider Sells $150,724.20 in Stock - MarketBeat
Arvinas, Inc. (NASDAQ:ARVN) CEO Sells $523,971.36 in Stock - MarketBeat
David K. Loomis Sells 1,214 Shares of Arvinas, Inc. (NASDAQ:ARVN) Stock - MarketBeat
Arvinas (NASDAQ:ARVN) Hits New 52-Week LowShould You Sell? - MarketBeat
Have Arvinas Insiders Been Selling Stock? - Simply Wall St
Arvinas's SWOT analysis: biotech firm's stock hinges on cancer drug trials - Investing.com
Arvinas’s SWOT analysis: biotech firm’s stock hinges on cancer drug trials - Investing.com UK
Arvinas chief scientific officer sells $70,238 in stock By Investing.com - Investing.com South Africa
Long Term Trading Analysis for (ARVN) - Stock Traders Daily
Arvinas president of R&D sells $150,752 in stock By Investing.com - Investing.com South Africa
Arvinas chief scientific officer sells $70,238 in stock - Investing.com
Arvinas Insider Sold Shares Worth $523,881, According to a Recent SEC Filing -February 25, 2025 at 06:49 am EST - Marketscreener.com
Arvinas president of R&D sells $150,752 in stock - Investing.com India
Arvinas Executives Sell Shares to Cover Tax Obligations - TradingView
Arvinas (ARVN) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Arvinas stock hits 52-week low at $16.55 amid market challenges - Investing.com Australia
Arvinas stock hits 52-week low at $16.55 amid market challenges By Investing.com - Investing.com South Africa
Arvinas (ARVN) Projected to Post Quarterly Earnings on Tuesday - Defense World
Arvinas (NASDAQ:ARVN) Trading 7.4% HigherHere's What Happened - MarketBeat
Arvinas (NASDAQ:ARVN) shareholders have endured a 72% loss from investing in the stock three years ago - Yahoo Finance
Arvinas (ARVN) to Release Quarterly Earnings on Tuesday - MarketBeat
Arvinas, Inc. (NASDAQ:ARVN) Sees Significant Growth in Short Interest - MarketBeat
All You Need to Know About Arvinas (ARVN) Rating Upgrade to Buy - MSN
Arvinas Operations describes new DGK-α inhibitors - BioWorld Online
What is HC Wainwright's Estimate for Arvinas Q3 Earnings? - MarketBeat
Arvinas Inc Azioni (ARVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.98%
8.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):